Trial Profile
Clopidogrel Resistance and Platelet Reactivity in Hispanic Females Undergoing Percutaneous Coronary Intervention
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary)
- Indications Acute coronary syndromes; Embolism and thrombosis
- Focus Therapeutic Use
- 25 Feb 2013 New trial record